13 results
10-K
2020 FY
NKTX
Nkarta Inc
25 Mar 21
Annual report
12:00am
if there is no patent challenge, (iii) 18 months after resolution of a lawsuit over the patents of the reference biologic in favor of the first … interchangeable biosimilar applicant, or (iv) 42 months after the first interchangeable biosimilar’s application has been approved if a patent lawsuit
8-K
EX-10.1
NKTX
Nkarta Inc
5 Oct 20
Nkarta Announces Leadership Changes
4:15pm
for the purpose of reporting or investigating a suspected violation of law, or (b) to disclose the Company’s trade secrets in an anti-retaliation lawsuit
424B4
l7q f34tx
10 Jul 20
Prospectus supplement with pricing info
9:35pm
S-1/A
24311ye8o4i4mx1p
2 Jul 20
IPO registration (amended)
5:17pm
S-1
qzo1o44
19 Jun 20
IPO registration
3:24pm
DRS/A
srqv477gww
19 May 20
Draft registration statement (amended)
12:00am
DRS/A
k7pmt
20 Apr 20
Draft registration statement (amended)
12:00am
DRS
x8jiu
28 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next